Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 5,864 shares at $5.05 ($30K) on 2016-08-11, disclosed to the SEC on 2016-08-15.
Open-market sale of $30k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.05 | 1,306 | $7K | 21.7% |
| 2 | $5.22 | 4,558 | $24K | 78.3% |
| Total | $5.18 avg | 5,864 | $30K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |